The clinical implications of HO-1 induction in diabetes are debatable, for example, the extent of HO-1 induction varies due to the presence of a microsatellite polymorphism in HO-1 promoter, which could cause unpredictable therapeutic effects [32]. The gene discussed is HMOX1; the disease is diabetes mellitus.